- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 22nd, 2007
"Nanotech has an incredibly broad application spectrum and the sector offers enormous opportunities," explains Gregg Early in The Real Nanotech Investor.
"My conservative favorite for 2008 is Bayer (OTC: BAYRY). Although the stock is up 50% since we first added it to our portfolio less than a year ago, its return isn't surprising given current market conditions.
"Bayer has a number of things going for it beyond its significant incorporation of nanotech into various product lines; it even sells Baytubes, proprietary ready-to-use, multi-walled carbon nanotubes. It's also a big, safe stock.
"But it's still undervalued relative to its pharma competitors. And it's a German company that has the spending power of a euro-based firm with significant exposure in every major developed and developing market in the world.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
World's most powerful X-ray takes a 'sledgehammer' to molecules September 14th, 2016
Researchers design solids that control heat with spinning superatoms: Carnegie Mellon University and Columbia University collaborators discover the cause of vastly different thermal conductivities in superatomic structural analogues September 8th, 2016
For first time, carbon nanotube transistors outperform silicon September 8th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Fighting cancer with sticky nanoparticles September 27th, 2016
Crystalline Fault Lines Provide Pathway for Solar Cell Current: New tomographic AFM imaging technique reveals that microstructural defects, generally thought to be detrimental, actually improve conductivity in cadmium telluride solar cells September 26th, 2016